Company news
Becton, Dickinson and Company news in 2026
Becton, Dickinson and Company's news releases, calls and decks from 2026, newest first.
BD to Announce Financial Results for its First Quarter of Fiscal 2026
January 27, 2026
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
January 27, 2026
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
January 23, 2026
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
January 21, 2026
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
January 15, 2026
BD Names Shawn Bevec as Senior Vice President of Investor Relations
January 14, 2026
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
January 13, 2026
BD To Host Virtual 2026 Annual Meeting of Shareholders
January 12, 2026
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
January 5, 2026
Calls in 2026
- Becton, Dickinson and (NYSE:BDX) Q4 2026 Earnings Call
Nov 5, 2026
Transcript - Becton, Dickinson and (NYSE:BDX) Q3 2026 Earnings Call
Aug 6, 2026
Transcript - Becton, Dickinson and (NYSE:BDX) Q2 2026 Earnings Call
May 7, 2026
Transcript - Becton, Dickinson and (NYSE:BDX) Q1 2026 Earnings Call
Feb 9, 2026
Transcript
Decks in 2026
- Q4 FY26 Earnings Presentation
Earnings · 29 slides · Nov 5, 2026
- Q3 2026 Earnings Presentation
Earnings · 23 slides · Aug 6, 2026
- Q2 2026 Earnings Presentation
Earnings · 23 slides · May 7, 2026
- Q1 2026 Earnings Presentation
Earnings · 22 slides · Feb 9, 2026